Strata Critical Medical (SRTA) Preferred Stock Liabilities (2019 - 2021)

Strata Critical Medical (SRTA) has 3 years of Preferred Stock Liabilities data on file, last reported at $225.0 million in Q1 2021.

• Quarterly Preferred Stock Liabilities fell 10.82% year-over-year to $225.0 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $225.0 million (down 10.82% YoY) and the FY2020 annual result came in at $226.1 million, changed N/A from the prior year.
• Preferred Stock Liabilities held at $225.0 million in Q1 2021 per SRTA's latest filing, from $226.1 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $252.3 million in Q1 2020 and bottomed at $225.0 million in Q1 2021.
• The 3-year median for Preferred Stock Liabilities is $244.6 million (2020), against an average of $241.2 million.
• The widest annual swing landed in 2020, when Preferred Stock Liabilities advanced 0.24%; it then dropped 10.82% in 2021.
• Tracing SRTA's Preferred Stock Liabilities over 3 years: stood at $246.6 million in 2019, then retreated by 8.32% to $226.1 million in 2020, then retreated by 0.48% to $225.0 million in 2021.
• Per Business Quant, the three latest SRTA Preferred Stock Liabilities figures stand at $225.0 million (Q1 2021), $226.1 million (Q4 2020), and $244.6 million (Q3 2020).

Peer Comparison